January 17, 2011
Keiji Nakamura, Ph. D. Pharma Forum Institute Kamakura, Japan http://www.pharma-fi.com/index.html Chemotherapeutic agents currently approved for the treatment of cancers may exhibit initial efficacy; however, the development of resistance to therapy and concerns over tolerability are common and generally limit treatment...read more